Page last updated: 2024-08-21

deoxyuridine and glucagon-like peptide 1

deoxyuridine has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bénardeau, A; Bosco, D; Brecheisen, M; Migliorini, C; Prummer, M; Sebokova, E; Sewing, S; Tobalina, L; Uhles, S; Wang, H; Wollheim, CB	1

Other Studies

1 other study(ies) available for deoxyuridine and glucagon-like peptide 1

Article	Year
Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo. Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:4 Topics: Animals; Apoptosis; Cells, Cultured; Deoxyuridine; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Immunohistochemistry; Insulin-Secreting Cells; Male; Peptides; Rats; Rats, Zucker; Receptors, Glucagon	2011

Article

Year

Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.

Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:4

Topics: Animals; Apoptosis; Cells, Cultured; Deoxyuridine; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Immunohistochemistry; Insulin-Secreting Cells; Male; Peptides; Rats; Rats, Zucker; Receptors, Glucagon

2011